Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Antitubercular agents. --- Multidrug-resistant tuberculosis --- MDR-TB (Multidrug-resistant tuberculosis) --- MDR tuberculosis --- Polydrug-resistant tuberculosis --- Drug resistance in microorganisms --- Multidrug resistance --- Tuberculosis --- Drugs, Antitubercular --- Tuberculostatic agents --- Antibacterial agents --- Chemotherapy. --- Chemotherapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Multidrug-resistant tuberculosis -- Congresses. --- Multidrug-resistant tuberculosis -- Prevention -- Congresses. --- Tuberculosis -- Congresses. --- Multidrug-resistant tuberculosis --- Tuberculosis --- Drug resistance --- Anti-Bacterial Agents --- Internationality --- Mycobacterium Infections --- Social Sciences --- Anti-Infective Agents --- Anthropology, Education, Sociology and Social Phenomena --- Actinomycetales Infections --- Therapeutic Uses --- Gram-Positive Bacterial Infections --- Pharmacologic Actions --- Bacterial Infections --- Chemical Actions and Uses --- Bacterial Infections and Mycoses --- Chemicals and Drugs --- Diseases --- International Cooperation --- Tuberculosis, Multidrug-Resistant --- Antitubercular Agents --- Medicine --- Public Health --- Health & Biological Sciences --- Infectious Diseases --- Communicable Diseases --- Prevention --- MDR-TB (Multidrug-resistant tuberculosis) --- MDR tuberculosis --- Polydrug-resistant tuberculosis --- Drug resistance in microorganisms --- Multidrug resistance

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions."--Publisher's website.

Antitubercular agents -- Congresses. --- Drug resistance -- Congresses. --- Electronic books. -- local. --- Multidrug-resistant tuberculosis -- Congresses. --- Tuberculosis -- Congresses. --- Multidrug-resistant tuberculosis --- Tuberculosis --- Drug resistance --- Antitubercular agents --- Congresses --- Internationality --- HIV Infections --- Tuberculosis, Multidrug-Resistant --- Antitubercular Agents --- Anti-Bacterial Agents --- Publication Formats --- Sexually Transmitted Diseases, Viral --- Lentivirus Infections --- Social Sciences --- Immunologic Deficiency Syndromes --- Retroviridae Infections --- Mycobacterium Infections --- Publication Characteristics --- Anti-Infective Agents --- Immune System Diseases --- Anthropology, Education, Sociology and Social Phenomena --- Sexually Transmitted Diseases --- Virus Diseases --- Actinomycetales Infections --- RNA Virus Infections --- Diseases --- Therapeutic Uses --- Gram-Positive Bacterial Infections --- Pharmacologic Actions --- Chemical Actions and Uses --- Bacterial Infections --- Bacterial Infections and Mycoses --- Chemicals and Drugs --- Infectious Diseases --- Medicine --- Health & Biological Sciences --- Drugs, Antitubercular --- Tuberculostatic agents --- Resistance to drugs --- MDR-TB (Multidrug-resistant tuberculosis) --- MDR tuberculosis --- Polydrug-resistant tuberculosis --- Antibacterial agents --- Pharmacology --- Drug resistance in microorganisms --- Multidrug resistance --- Chemotherapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, are serious threats to global public health and jeopardizes efforts to effectively control the disease. These important developments and the availability of new evidence related to the diagnosis and management of drug-resistant tuberculosis have mandated an urgent update of existing guidelines. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency updated edition 2008 replaces previous publications by the Wor

Antitubercular agents. --- Multidrug-resistant tuberculosis -- Chemotherapy. --- Multidrug-resistant tuberculosis -- Prevention. --- Multidrug-resistant tuberculosis --- Antitubercular agents --- HIV infections --- Comorbidity --- Highly active antiretroviral therapy --- Sexually Transmitted Diseases, Viral --- Tuberculosis --- Immunologic Deficiency Syndromes --- Drug Therapy, Combination --- Lentivirus Infections --- Anti-Bacterial Agents --- Therapeutics --- Immune System Diseases --- Retroviridae Infections --- Anti-Infective Agents --- Mycobacterium Infections --- Sexually Transmitted Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Therapeutic Uses --- Actinomycetales Infections --- RNA Virus Infections --- Virus Diseases --- Diseases --- Gram-Positive Bacterial Infections --- Pharmacologic Actions --- Chemical Actions and Uses --- Bacterial Infections --- Chemicals and Drugs --- Bacterial Infections and Mycoses --- HIV Infections --- Drug Therapy --- Tuberculosis, Multidrug-Resistant --- Antitubercular Agents --- Antiretroviral Therapy, Highly Active --- Public Health --- Health & Biological Sciences --- Communicable Diseases --- Chemotherapy --- Prevention --- Treatment --- Highly active antiretroviral therapy. --- Treatment. --- Chemotherapy. --- Prevention. --- MDR-TB (Multidrug-resistant tuberculosis) --- MDR tuberculosis --- Polydrug-resistant tuberculosis --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Antiretroviral therapy, Highly active --- HAART (Chemotherapy) --- Coexisting disease --- Coexisting illness --- Drugs, Antitubercular --- Tuberculostatic agents --- Drug resistance in microorganisms --- Multidrug resistance --- Lentivirus infections --- Sexually transmitted diseases --- Chemotherapy, Combination --- Epidemiology --- Antibacterial agents